DrugDashboards

Antiseptic Skin Cleanser

Chlorhexidine Gluconate 4% · CHLORHEXIDINE GLUCONATE 4 mg/100mL · Liquid · Topical · AmerisourceBergen Drug Corporation

NDC 46122-0137-43 · 473 mL in 1 BOTTLE · NDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 18% over the past year, to $0.0184 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.01$0.02$0.03Sep 2021Sep 2026$0.0184
48 price points · per MLSource: CMS NADAC

Estimated fill cost

Estimated WAC per mLestimate
$0.019
No Texas or California filing exists for this NDC — this figure is derived, not filed.

This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.

Medicaid spend (2025)

$1,281
66 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for chlorhexidine gluconate (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA019125
TE code
Approval date
Dec 24, 1984
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Chlorhexidine Gluconate 4% (Liquid)

LabelerStrengthFirst seenLast seen
Xttrium Laboratories, Inc.CHLORHEXIDINE GLUCONATE 4 mg/100mLJul 15, 2026Sep 3, 2026
AmerisourceBergen Drug CorporationCHLORHEXIDINE GLUCONATE 4 mg/100mLJul 15, 2026Sep 2, 2026
Chain Drug Marketing Association Inc.CHLORHEXIDINE GLUCONATE 4 mg/100mLJul 15, 2026Sep 2, 2026
CVS Pharmacy, Inc.CHLORHEXIDINE GLUCONATE 4 g/100mLJul 15, 2026Sep 2, 2026
Meijer Distribution, Inc.CHLORHEXIDINE GLUCONATE 4 mg/100mLJul 15, 2026Sep 2, 2026
Rite AidCHLORHEXIDINE GLUCONATE 4 g/100mLJul 15, 2026Sep 2, 2026
Rite Aid CorporationCHLORHEXIDINE GLUCONATE 4 mg/100mLJul 15, 2026Sep 2, 2026
Topco Associates LLCCHLORHEXIDINE GLUCONATE 4 mg/100mLJul 15, 2026Sep 2, 2026
Walgreen Co.CHLORHEXIDINE GLUCONATE 4 mg/100mLJul 15, 2026Sep 2, 2026
Xttrium Laboratories, Inc.CHLORHEXIDINE GLUCONATE 4 g/100mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Antiseptic Skin Cleanser — NDC 46122-0137-43," retrieved September 3, 2026, https://drugdashboards.com/drug/46122013743.

Free to cite with attribution — see how the data is put together.